German Scientists Race to Develop Non-Hormonal Birth Control Alternatives

A new research initiative called Prevent is working to develop non-hormonal contraceptives for both women and men. The project aims to address growing concerns about the side effects of hormonal birth control, which have led many to seek alternatives. Backed by €3 million in federal funding, the collaboration involves leading German universities and hospitals.

The Prevent project brings together Goethe University Frankfurt, University Hospital Bonn, and Ludwig Maximilian University of Munich. Their goal is to create safe, reversible contraceptives that avoid the health risks linked to hormonal methods, such as nausea and blood clots. The team is using a precision biology approach to target proteins found only in sperm or egg cells, aiming to block sperm mobility and prevent fertilisation without affecting overall health.

Rather than relying on hormones, the researchers are using a specialised drug discovery platform and chemical probes. These tools help validate infertility-related genes as potential targets for new contraceptive ingredients. The project also emphasises full fertility restoration once the contraceptive is no longer used. This effort is part of a broader trend in reproductive health research. Since 2023, numerous global projects have explored non-hormonal methods, including male contraceptives, immunological approaches, and barrier technology. Major players like the NIH, universities, and biotech firms are driving these initiatives, though no single database tracks all ongoing work.

The Prevent project plans to deliver scientific evidence that could shape future clinical trials for non-hormonal contraceptives. If successful, the research may expand contraceptive options and support reproductive autonomy worldwide. The German government's funding ensures the project will continue through 2029.